Related Experiment Video
Updated: Jun 25, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
CXCL14 and insulin action
1The Tokyo Metropolitan Institute of Medical Science, Tokyo Metropolitan Organization for Medical Research, Bunkyo-ku, Tokyo 113-8613, Japan.
Abstract:
CXCL14 is a member of CXC chemokine family. The physiological roles of CXCL14 and its receptor/signal transduction pathway remain largely unknown. In the human, CXCL14 exhibits chemoattractive activity for activated monocytes and dendritic precursor cells. Recruitment of dendritic precursor cells and inhibition of angiogenesis by CXCL14 suggest that this chemokine has a tumor suppressive function. However, analysis of CXCL14-deficient (CXCL14(-/-)) mice revealed that CXCL14 is dispensable for development and maintenance of tissue macrophages and dendritic cells. CXCL14(-/-) female mice, but not male mice, weigh significantly less than wild-type mice and are protected from obesity-induced hyperglycemia, hyperinsulinemia, hypoadiponectinemia, and insulin resistance. CXCL14 expression is elevated in white adipose tissue (WAT) of high-fat diet (HFD)-fed obese mice and leptin-system defective mutant mice. Phenotypes of HFD-fed CXCL14(-/-) female mice indicate that CXCL14 is involved in recruitment of macrophages into WAT, which causes chronic inflammation and contributes to insulin resistance. Transgenic overexpression of CXCL14 in skeletal muscle restores obesity-induced insulin resistance in CXCL14(-/-) female mice. In addition, CXCL14 attenuates insulin-stimulated glucose uptake in cultured myocytes. Based on these data, it is evident that CXCL14 is a novel regulator of glucose metabolism that acts by recruiting macrophages to WAT and interacting with insulin signaling pathways in skeletal muscle.
Insights
Chemokine CXCL14 (C-X-C motif chemokine ligand 14) deficiency protects female mice from obesity and insulin resistance by reducing inflammation in white adipose tissue. CXCL14 regulates glucose metabolism and insulin signaling.
Area of Science:
- Immunology
- Metabolic research
- Endocrinology
Background:
- The physiological roles of CXCL14 (C-X-C motif chemokine ligand 14) are largely unknown.
- CXCL14 exhibits chemoattractant activity for monocytes and dendritic precursor cells, suggesting a potential tumor suppressive function.
- Previous studies indicated CXCL14 is dispensable for immune cell development in mice.
Purpose of the Study:
- To investigate the physiological roles of CXCL14 in vivo, particularly concerning metabolism and inflammation.
- To elucidate the function of CXCL14 in obesity-induced insulin resistance.
Main Methods:
- Analysis of CXCL14-deficient (CXCL14(-/-)) mice fed a high-fat diet (HFD).
- Assessment of metabolic parameters including body weight, glucose levels, insulin sensitivity, and adipose tissue macrophage infiltration.
- Investigation of CXCL14's effect on glucose uptake in cultured myocytes and insulin signaling pathways.
Main Results:
- CXCL14(-/-) female mice are protected from obesity and associated metabolic dysfunction (hyperglycemia, hyperinsulinemia, insulin resistance) compared to wild-type mice.
- CXCL14 expression is elevated in white adipose tissue (WAT) of obese mice.
- CXCL14 promotes macrophage recruitment into WAT, contributing to chronic inflammation and insulin resistance; it also attenuates insulin-stimulated glucose uptake in myocytes.
Conclusions:
- CXCL14 is a novel regulator of glucose metabolism and insulin resistance.
- CXCL14 mediates its effects by influencing macrophage infiltration into WAT and interacting with insulin signaling in skeletal muscle.
- Targeting CXCL14 may offer a therapeutic strategy for metabolic disorders like insulin resistance.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Insulin Secretory Vesicles
Cell Specific Gene Expression

